Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15693103 | 0.83 | DGKA (0.37) | ALDH1A1 | |
| SCHEMBL28688703 | 0.82 | GAA (0.46) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL12746175 | 0.81 | GAA (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL235746 | 0.81 | GAA (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL232993 | 0.80 | GAA (0.55) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL21052480 | 0.80 | GAA (0.55) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL798062 | 0.80 | GAA (0.55) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL11861490 | 0.78 | GAA (0.52) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL7563037 | 0.78 | GAA (0.52) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL927785 | 0.78 | GAA (0.52) | GAAMGAMSIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6815500-B1 | PREPARING COMPOSITION OF POLYMER MATRIX SURROUNDING RUBBER NODULES BY POLYMERIZING VINYLAROMATIC MONOMER IN PRESENCE OF RUBBER, STABLE FREE RADICAL WHICH IS NOT LINKED TO RUBBER, AND POLYMERIZATION INITIATOR WITH GRAFTING CHARACTER | ATOFINA (FR) | 2004-11-09 | — | — | US | claimed |
| US-6815500-B1 | PREPARING COMPOSITION OF POLYMER MATRIX SURROUNDING RUBBER NODULES BY POLYMERIZING VINYLAROMATIC MONOMER IN PRESENCE OF RUBBER, STABLE FREE RADICAL WHICH IS NOT LINKED TO RUBBER, AND POLYMERIZATION INITIATOR WITH GRAFTING CHARACTER | ATOFINA (FR) | 2004-11-09 | — | — | US | disclosed |
| US-6646079-B2 | For the preparation of polymers with the distribution of multimodal molecular masses; mechanical strength of polymers produced | ATOFINA (FR) | 2003-11-11 | — | — | US | disclosed |
| US-20020040117-A1 | Multimodal polymers by controlled radical polymerization in the presence of alkoxyamines | ATOFINA (FR) | 2002-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040117-A1 | Multimodal polymers by controlled radical polymerization in the presence of alkoxyamines | PNMT, OPRM1, PRMT1 | GAA 3917/4885MGAM 1512/4885SI 4315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.